On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...